2017 Vietnam Automated Microbiology Market: Molecular Diagnostics, Identification, Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics– Specimen, Test, and Sales Forecasts, Competitive Strategies, Opportunities

SOURCE: Report Buyer

Jan 2017 • By Venture Planning Group • 500 pages Summary This new report from VPGMarketResearch.com examines current and emerging assays; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay and application; profiles leading players and potential market entrants; and suggests alternative market penetration strategies for suppliers. Rationale The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon. The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide. This report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies. Market Segmentation Analysis – Volume and sales forecasts for over 100 infectious disease assays by individual test. – Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy). Specimen Types – Urine – Sterile Fluids: Blood, Serum, CSF – Throat Swabs, Respiratory Secretions – Genital Secretions – Stool – Abscess/Wound – Sputum – Saliva Applications – Microbial Identification – Antibiotic Susceptibility – Urine Screening – Blood Cultures Review of Major Automated Systems – Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers. Infectious Diseases Analyzed in the Report AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia. Technology Review – Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market. – Global listings of companies developing or marketing microbiology products by individual test. Competitive Assessments – Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D. Opportunities and Strategic Recommendations – Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years. – Design criteria for decentralized testing products. – Alternative market penetration strategies. – Potential market entry barriers and risks. Contains 500 pages and 54 tables

Table of Contents I. Market Overview A. Introduction 1. Major Factors Affecting Market Penetration of Microbiology Instrumentation 2. Traditional Practices 3. Technological Challenges 4. Automation: Impact on the Microbiology Laboratory and the Patient B. Major Specimen Types 1. Urine 2. Sterile Fluids: Blood, Serum, and CSF 3. Throat Swabs and Respiratory Secretions 4. Genital Secretions 5. Stool 6. Abscess/Wound 7. Sputum 8. Saliva C. Test Applications 1. Microbial Identification 2. Antibiotic Susceptibility 3. Urine Screening a. Photometry b. Bioluminescence c. Colorimetric Filtration d. Enzymatic Detection e. Optical Detection 4. Blood Cultures D. Major Microbiology Automated and Semi-Automated Systems 1. Multiple Purpose Microbiology Systems 2. Specialized Microbiology Systems 3. Molecular Diagnostic Systems 4. Immunodiagnostic Systems E. Emerging Diagnostic Technologies II. Market Size and Growth: Specimen, Test Volume, Application, and Sales Forecasts for 100 Assays III. Major Product Development Opportunities IV. Design Criteria for Decentralized Testing Products V. Alternative Market Penetration Strategies VI. Potential Market Entry Barriers and Risks VII. Competitive Assessments – Abbott – Affymetrix – Agilent Technologies – Applied Gene Technologies – Arca Biopharma – Beckman Coulter/Danaher – Becton Dickinson – Biokit – bioMerieux – Bio-Rad – Biotest – CellMark Forensics/Lab Corp – Cepheid – Decode Genetics – Diadexus – Diamedix/Erba – DiaSorin – Eiken Chemical – Elitech Group – Enzo Biochem – Exact Sciences – Fujirebio – Grifols – Hologic/Gen-Probe – ID Biomedical/GSK – Illumina – Kreatech/Leica – Li-Cor Biosciences – Lonza – Monogram Biosciences – Myriad Genetics – Ortho-Clinical Diagnostics – Perkin Elmer/Caliper – Proteome Sciences – Qiagen – Roche – Scienion – Sequenom – SeraCare – Shimadzu – Siemens – Sierra Molecular – Takara Bio – Tecan – Thermo Fisher – Wallac/PE – Wako List of Tables Microbiology Specimen Volume Forecast by Type Microbiology Test Volume Forecasts by Application Microbiology Consumables Market Forecast by Application Infectious Disease Test Volume Forecast by Assay Infectious Disease Diagnostics Market Forecast by Test Infectious Disease Blood Screening NAT Volume Forecast by Assay Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay Major Companies Developing or Marketing AIDS Tests Major Companies Developing or Marketing Adenovirus Tests Major Companies Developing or Marketing Bartonella Tests Major Companies Developing or Marketing Campylobacter Tests Major Companies Developing or Marketing Candida Tests Major Companies Developing or Marketing Chlamydia Tests Major Companies Developing or Marketing Clostridium Tests Major Companies Developing or Marketing Coronavirus Tests Major Companies Developing or Marketing Cryptosporidium Tests Major Companies Developing or Marketing CMV Tests Major Companies Developing or Marketing Echovirus Tests Major Companies Developing or Marketing Enterovirus Tests Major Companies Developing or Marketing EBV Tests Major Companies Developing or Marketing Giardia Tests Major Companies Developing or Marketing Gonorrhea Tests Major Companies Developing or Marketing Hantavirus Tests Major Companies Developing or Marketing Helicobacter Pylori Tests Major Companies Developing or Marketing Hepatitis Tests Major Companies Developing or Marketing Herpes Tests Major Companies Developing or Marketing Influenza Tests Major Companies Developing or Marketing Legionella Tests Major Companies Developing or Marketing Lyme Disease Tests Major Companies Developing or Marketing Lymphogranuloma Tests Major Companies Developing or Marketing Malaria Tests Major Companies Developing or Marketing Measles Tests Major Companies Developing or Marketing Meningitis Tests Major Companies Developing or Marketing Microsporidium Tests Major Companies Developing or Marketing Mononucleosis Tests Major Companies Developing or Marketing Mumps Tests Major Companies Developing or Marketing Mycoplasma Tests Major Companies Developing or Marketing Papilloma Virus Tests Major Companies Developing or Marketing Parvovirus Tests Major Companies Developing or Marketing Pneumonia Tests Major Companies Developing or Marketing RSV Tests Major Companies Developing or Marketing Rotavirus Tests Major Companies Developing or Marketing Rubella Tests Major Companies Developing or Marketing Salmonella Tests Major Companies Developing or Marketing Septicemia Tests Major Companies Developing or Marketing Shigella Tests Major Companies Developing or Marketing Staphylococci Tests Major Companies Developing or Marketing Streptococci Tests Major Companies Developing or Marketing Syphilis Tests Major Companies Developing or Marketing Toxoplasmosis Tests Major Companies Developing or Marketing Trichomonas Tests Major Companies Developing or Marketing Tuberculosis Tests Major Companies Developing or Marketing West Nile Tests Major Companies Developing or Marketing Yersinia Tests

Note: We are not responsible for typo error, price change, substitute item, or available of item from online ads.

]]>